The Popularity of BOTOX®: Charlotte’s Dr. Adam Augenstein Notes Its Rise
Statistics show that botulinum-toxin based injectables, with BOTOX® as the most popular example, are being increasingly used across the United States
While patients continue to choose plastic surgery when they want to make a cosmetic change to their faces, a particularly notable trend is the increasing popularity of nonsurgical options, such as BOTOX®. Charlotte’s Dr. Adam Augenstein noted with interest that the most recent statistics available from the American Society of Plastic Surgeons revealed a three percent increase in the use of cosmetic minimally invasive procedures as a whole across the United States from 2015 to 2016.
While treatments from chemical peels to soft-tissue fillers saw a jump in application, the clear favorite was a category titled “botulinum toxin Type A,” made up of injectables that temporarily relax muscles to reduce the appearance of related wrinkles and lines. This group includes Dysport®, Xeomin®, and the global leader: BOTOX® Cosmetic.
With BOTOX® contributing the vast bulk of that category’s success, the number of treatments performed in this country, according to the survey, leapt from 6,757,198 in 2015 to 7,056,255 in 2016. That’s a rise of four percent, comprising just shy of 300,000 people.
While the FDA has approved BOTOX® for various cosmetic uses since the early 2000s—and numerous medical uses in the decades prior to that—it is still gaining attention and notoriety. TIME wrote a cover story on the popular injectable earlier in 2017, highlighting the many uses for BOTOX® that have developed over the years and noting multiple potential new uses. Current studies, for instance, are exploring whether BOTOX® can play a role in helping curb the symptoms of depression in people.
The ASPS survey focused solely on cosmetic uses of BOTOX® and its fellow botulinum-based brethren. Perhaps not surprisingly, while the increase in these treatments performed from 2015 to 2016 was relatively modest, growth since the year 2000 was a formidable 797 percent.
Among the other details noted in the 2016 report:
BOTOX® is approved by the FDA specifically to reduce the appearance of frown lines on the forehead and crow’s feet. That said, many doctors also use it for what are known as “off label” uses, which are common and perhaps even well studied and established—but not officially endorsed by the Food and Drug Administration.
The cosmetic works by preventing contraction-causing signals from reaching their intended muscles. If these muscles remain still, they refrain from pulling the skin above, which reduces the appearance of lines that grow increasingly pronounced over time. These wrinkles are known as “dynamic wrinkles” because they form due to repetitive motion.
The ASPS compiles its annual report examining trends in cosmetic procedures and treatments by distributing surveys to member physicians and combining results with information from a national plastic surgery database, after which the numbers are aggregated and extrapolated.
Source: Free Articles from ArticlesFactory.com
ABOUT THE AUTHOR
Dr. Adam Augenstein is a plastic surgeon with double board certification: one from the American Board of Plastic Surgery and one from the American Board of Otolaryngology—Head and Neck Surgery. He offers surgical procedures (such as tummy tuck, breast augmentation, and facelift) and nonsurgical treatments (such as microneedling, chemical peels, Profound RF®, and BOTOX®) at his Charlotte, NC, plastic surgery practice. For more information or to reach out, visit his Contact Us page or call (704) 837-1150.